Organon signs deal for Chinese drugs | Chemical & Engineering News
Volume 85 Issue 3 | p. 33 | Concentrates
Issue Date: January 15, 2007

Organon signs deal for Chinese drugs

Department: Business

Akzo Nobel's Organon drug arm and Huya Bioscience International have formed a collaboration to search for new pharmaceutical compounds that originate in China. With offices in San Diego and Shanghai, Huya identifies, licenses, and develops Chinese drug candidates for commercialization in Western markets. Organon has acquired an equity interest in Huya as part of the deal. In the past year, Organon has entered into research alliances with two other Chinese biotech companies, Shanghai Genomics and HD Biosciences.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment